07:00 , Apr 14, 2011 |  BC Innovations  |  Distillery Therapeutics

Indication: Endocrine disease

Indication Target/marker/pathway Summary Licensing status Publication and contact information Endocrine disease Obesity Neuropeptide Y receptor Y2 (NPY2R); NPY4R Studies in mice suggest that a lipidated peptide agonist of NPY2R and NPY4R could help treat obesity....
08:00 , Jan 29, 2009 |  BC Innovations  |  Cover Story

Wising up to NPYs

In the mid-1990s, neuropeptide Y was thought to be a promising obesity target based on its activity in the CNS as a potent feeding stimulator. However, the approach didn't succeed and only one company is...
01:42 , Jan 16, 2009 |  BC Extra  |  Financial News

7TM raises $13.4 million

7TM (Horsholm, Denmark) raised DKK75 million ($13.4 million) in a private round through existing investors. 7TM has two compounds in Phase I/II testing to treat obesity: obinepitide , a synthetic analog of human hormones PYY3-36...